In this study, we describe a newly established patient-derived UPS cell line named JBT19, which simultaneously expresses PD-L1, the ligand for PD-1, and collagen, the ligand for LAIR-1. This evidence concerns the gene LAIR1 and undifferentiated pleomorphic sarcoma.